A Chart Review to Evaluate the Safety and Efficacy of MeRT on Subjects With ASD

Wave Neuroscience logo

Wave Neuroscience

Status

Completed

Conditions

Autistic Disorder

Treatments

Other: MeRT Efficacy Chart Review

Study type

Observational

Funder types

Industry

Identifiers

NCT02758496
MeRT-016

Details and patient eligibility

About

The purpose of this study is to evaluate the safety and efficacy of Magnetic EEG/ECG-Guided Resonance Therapy (MeRT) on subjects with Autism Spectrum Disorder (ASD).

Full description

This is a retrospective chart review of 200 consecutive charts of subjects ages 2-20 years old seen at the Brain Treatment Center between 2010 and 2015. The review is designed to evaluate the safety and efficacy of Magnetic Electroencephalogram/Electrocardiogram(EEG/ECG)-Guided Resonance Therapy (MeRT) on subjects with Autism Spectrum Disorder (ASD).

Enrollment

141 patients

Sex

All

Ages

2 to 20 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Must have completed a baseline EEG at the Brain Treatment Center (BTC)
  • Age between 2 and 20 years old at initial visit
  • Must have a diagnosis of ASD according to the prevailing standard at that time (i.e., Diagnostic and Statistical Manual-IV (DSM-IV)) (ASD Group only)

Must have received Magnetic EEG/ECG-Guided Resonance Therapy (MeRT) for more than (5) sessions (ASD Group only)

Exclusion criteria

Clinically significant abnormality or clinically significant unstable medical condition during treatment that in the Investigator's judgment may have may limited interpretation of the results.

Trial design

141 participants in 2 patient groups

ASD Subjects
Description:
Approximately two hundred (200) male and female subjects of any ethnic background between the ages of 2-20 years old seen at the Brain Treatment Center (BTC) between 2010 and 2015.
Treatment:
Other: MeRT Efficacy Chart Review
Healthy Controls
Description:
Twenty (20) male and female subjects of any ethnic background between the ages of 2-20 years old with 'neurotypical' EEGs will be selected for comparison to the ASD group
Treatment:
Other: MeRT Efficacy Chart Review

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems